Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 7,421 shares (grant or award)
  2. 4 Grant or award Director acquired 7,421 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Interim President and CEO acquired 7,050 shares (grant or award)
  6. 4 Grant or award Director acquired 7,119 shares (grant or award)
  7. 4 Grant or award Director acquired 7,119 shares (grant or award)
  8. 4 Grant or award Director acquired 7,119 shares (grant or award)
  9. 4 Grant or award Director acquired 9,255 shares (grant or award)
  10. 4 Grant or award Vice President and CFO acquired 39,767 shares (grant or award)
  11. 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 39,767 shares (grant or award)
  12. 4 Grant or award SVP Ops & Prod Dev acquired 24,548 shares (grant or award)
  13. 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 1,062 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and CEO gave up 5,397 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP Ops & Prod Dev gave up 481 shares (to pay taxes)
  16. 4 Shares withheld for taxes Vice President and CFO gave up 612 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP - New Bus Dev & Spec Sales gave up 1,589 shares (to pay taxes)
  18. 4 Shares withheld for taxes Vice President and CFO gave up 1,460 shares (to pay taxes)
  19. 4 Shares withheld for taxes President and CEO gave up 6,883 shares (to pay taxes)
  20. 4 Open-market buy Director bought 5,000 shares at an average $45.10 ($225,510)

Page 19 of 42 · 835 filings